These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
112 related items for PubMed ID: 10454778
21. Successful treatment of collapsing focal segmental glomerulosclerosis with a combination of rituximab, steroids and ciclosporin. Kaito H, Kamei K, Kikuchi E, Ogura M, Matsuoka K, Nagata M, Iijima K, Ito S. Pediatr Nephrol; 2010 May; 25(5):957-9. PubMed ID: 20033219 [Abstract] [Full Text] [Related]
22. Unusual post-transplantation recurrence of focal segmental glomerulosclerosis which resolved with cyclosporine but not with sirolimus. Skhiri H, Morelon E, Noel LH, Mamzer-Bruneel MF, Legendre C, Peraldi MN, Kreis H. Transpl Int; 2005 Apr; 18(4):458-60. PubMed ID: 15773967 [Abstract] [Full Text] [Related]
23. Effect of concomitant administration of cyclosporine and ketoconazole in children with focal segmental glomerulosclerosis. El-Husseini A, El-Basuony F, Mahmoud I, Donia A, Hassan N, Sayed-Ahmed N, Sobh M. Am J Nephrol; 2004 Apr; 24(3):301-6. PubMed ID: 15133323 [Abstract] [Full Text] [Related]
24. Therapy of focal and segmental glomerulosclerosis with methylprednisolone, cyclosporine A, and prednisone. Waldo FB, Benfield MR, Kohaut EC. Pediatr Nephrol; 1998 Jun; 12(5):397-400. PubMed ID: 9686959 [Abstract] [Full Text] [Related]
25. The efficacy of cyclosporine A in adult nephrotic syndrome with minimal change disease and focal-segmental glomerulosclerosis: a multicenter study in Korea. Lee HY, Kim HS, Kang CM, Kim SG, Kim MJ. Clin Nephrol; 1995 Jun; 43(6):375-81. PubMed ID: 7554521 [Abstract] [Full Text] [Related]
26. Immunosuppressive treatment of idiopathic focal segmental glomerulosclerosis: a five-year follow-up study. Goumenos DS, Tsagalis G, El Nahas AM, Shortland JR, Davlouros P, Vlachojannis JG, Brown CB. Nephron Clin Pract; 2006 Jun; 104(2):c75-82. PubMed ID: 16785738 [Abstract] [Full Text] [Related]
27. Impact of the National Institutes of Health Focal Segmental Glomerulosclerosis (NIH FSGS) clinical trial on the treatment of steroid-resistant FSGS. Canetta PA, Radhakrishnan J. Nephrol Dial Transplant; 2013 Mar; 28(3):527-34. PubMed ID: 23248028 [Abstract] [Full Text] [Related]
28. Pulse cyclophosphamide therapy for steroid-resistant focal segmental glomerulosclerosis in children. Al Salloum AA. Ann Saudi Med; 2004 Mar; 24(1):27-30. PubMed ID: 15310010 [Abstract] [Full Text] [Related]
29. Different targets for treating focal segmental glomerular sclerosis. Coppo R. Contrib Nephrol; 2013 Mar; 181():84-90. PubMed ID: 23689570 [Abstract] [Full Text] [Related]
30. An update on the treatment options for focal segmental glomerulosclerosis. Meyrier A. Expert Opin Pharmacother; 2009 Mar; 10(4):615-28. PubMed ID: 19284364 [Abstract] [Full Text] [Related]
31. Review on diagnosis and treatment of focal segmental glomerulosclerosis. Deegens JK, Steenbergen EJ, Wetzels JF. Neth J Med; 2008 Jan; 66(1):3-12. PubMed ID: 18219061 [Abstract] [Full Text] [Related]
35. Long-term treatment of focal segmental glomerulosclerosis in children with cyclosporine given as a single daily dose. Chishti AS, Sorof JM, Brewer ED, Kale AS. Am J Kidney Dis; 2001 Oct; 38(4):754-60. PubMed ID: 11576878 [Abstract] [Full Text] [Related]
40. A case report of nephrotic syndrome due to collapsing focal segmental glomerulosclerosis treated with low-density lipoprotein apheresis. Miyazono M, Tomiyoshi Y, Kishi T, Ikeda Y, Sakemi T, Sanai T, Node K. Ther Apher Dial; 2008 Aug; 12(4):333-6. PubMed ID: 18789122 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]